Peter Byrne is a partner in the Capital Markets Group. Peter represents both issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, secondary and follow-on offerings, debt offerings, debt exchange offers and tender offers, and PIPE offerings. Peter also represents companies with respect to general corporate and securities matters, including in connection with mergers and acquisitions and restructurings, corporate governance issues, Exchange Act reporting obligations and stock exchange requirements. Peter regularly represents both issuers and underwriters in special purpose acquisition company (SPAC) IPOs and both acquirers and targets in connection with “de-SPAC” business combinations. Peter was recognized in the Legal 500 US 2025 Capital Markets: Equity Offerings category.
Prior to joining Paul, Weiss, Peter’s experience includes:
Equity Capital Markets
- Accel Partners as investor in connection with the $700 million PIPE issued by Nebius Group
- Black Knight Financial Services in its $507 million initial public offering and related “Up-C” restructuring
- Braze in its $572 million initial public offering
- Cotiviti Holdings in its $246 million initial public offering
- Elanco Animal Health in its spin-off from parent company Eli Lilly and Company and $1.7 billion initial public offering
- INC Research in its $173 million initial public offering
- Lehigh Gas Partners in its $137 million initial public offering and related master limited partnership restructuring
- Lexeo Therapeutics in its $100 million initial public offering
- Marinus Pharmaceuticals in its $45 million initial public offering
- Sanofi in its approximately $6.7 billion sale of a portion of its stake in Regeneron Pharmaceuticals and related approximately $5 billion share repurchase by Regeneron
- Wise Group in its reorganization and initial listing on Nasdaq
- Various sponsor-backed, public companies in secondary offerings
- Various public companies in follow-on offerings, ATM offerings, PIPE transactions, equity lines of credit and other financings
Debt Capital Markets
- Avolon Holdings Funding Limited, a wholly-owned subsidiary of Avolon Holdings Limited in five separate Rule 144A offerings of senior notes, totaling $7.75 billion
- Campbell Soup Company in its:
- registered $5.3 billion senior unsecured fixed and floating rate notes offering to, in part, finance its $6.1 billion acquisition of Snyder’s-Lance
- its registered $1 billion senior unsecured notes offering
- Core Scientific in its Rule 144A offering of $550 million 0.00% convertible senior notes
- Elanco Animal Health in its Rule 144A offering of $2 billion of senior unsecured notes
- Underwriters in the offering of $1 billion of 5.625% senior unsecured notes of ESAB Corporation\Global Aircraft Leasing, an affiliate of Avolon Holdings Limited, in its Rule 144A offering of $200 million of senior PIK toggle notes
- A large New York real estate company in a series of shelf note private placements
- Norwegian Cruise Line Holdings in matters related to its $680 million senior unsecured notes offering to finance its acquisition of Prestige Cruises International
- Park Aerospace Holdings, a wholly-owned subsidiary of Avolon Holdings Limited, in three separate Rule 144A offerings of senior notes totaling $5.35 billion used, in part, to finance Avolon Holdings Limited’s acquisition of C2 Aviation Capital
- Verizon Communications in financing matters in connection with its $4.4 billion acquisition of AOL
Complex Capitalizations, Liability Management and Restructuring Transactions
- Campbell Soup Company in its $1.2 billion waterfall tender offer for repurchase of certain senior notes and $500 million redemption of certain other senior notes to reduce outstanding indebtedness
- Catalina Marketing in a $1.9 billion restructuring involving a debt-for-equity exchange with its first-and second-lien lenders, pursuant to a pre-packaged Chapter 11 bankruptcy
- Cerberus in its $315.5 million investment in Eos through a delayed draw term loan and the purchase of non-voting preferred stock and penny warrants
- CTI Foods in its restructuring and bankruptcy proceedings under Chapter 11, which included the exchange of common stock for existing claims
- Enjoy Technology in its exploration of strategic alternatives and Chapter 11 bankruptcy
- Genworth Holdings in the multiple solicitations of consents from the holders of eight series of its outstanding notes to amend its indentures governing such notes
- Goldman Sachs in a secondary offering of common stock of ESAB Corporation held by Enovis Corporation and simultaneous debt-for-cash swap to pay down indebtedness of Enovis held by Goldman Sachs
- GulfMark Offshore in its restructuring and bankruptcy proceedings under Chapter 11, which included issuances of new common stock and new series of warrants pursuant to a rights offering and the exchange of common stock and warrants for existing claims
- Halcon Resources in its restructuring and bankruptcy proceedings under Chapter 11, which included the issuance of new common stock pursuant to a rights offering and the exchange of common stock and warrants for existing claims
- Highbridge Capital Management in the exchange of convertible notes for new second lien convertible notes, warrants and common stock of Senseonics Holdings and a concurrent first lien convertible term loan
- J.Crew Group and its affiliates in their review of strategic alternatives and reorganization pursuant to Chapter 11 proceedings
- PG&E and its subsidiary Pacific Gas and Electric Company in the restructuring of liabilities, including approximately $18 billion of issued senior unsecured notes and pollution control bonds and general securities matters in connection with their Chapter 11 bankruptcy
- Secured noteholders of Seadrill in connection with Seadrill's Chapter 11 bankruptcy
- Issuers and investors in connection with digital asset treasury company formations
SPAC Transactions
- Biote in its business combination with Haymaker Acquisition Corp. III at an implied enterprise value of $737 million
- BowX Acquisition in its business combination with WeWork at an implied enterprise value of $9 billion and concurrent $800 million PIPE
- Fortress Value Acquisition in its business combination with MP Materials at an implied enterprise value of $1.5 billion and concurrent $200 million PIPE offering
- Infleqtion in its business combination with Churchill Capital Corp X at an implied enterprise value of $2.4 billion and concurrent $125 million PIPE offering
- IQM Oy in its business combination with Real Asset Acquisition Corp. at an implied value of $2.4 billion, its dual listing in U.S. and Finland, and concurrent $134M PIPE offering
- Perceptive Capital Solutions in its business combination with Freenome Holdings at an implied value of $1.1 billion and concurrent $240 million PIPE offering
- TPB Acquisition Corp. I in its business combination with Lavoro at an implied enterprise value of $1.2 billion and concurrent $100 million PIPE offering
- Xanadu Quantum Technologies Limited in its business combination with Crane Harbor Acquisition Corp. at an implied enterprise value of
$3.1 billion, dual listing in U.S. and Canada, and simultaneous $275 million PIPE
- Issuers in over 15 SPAC IPOs and as post-IPO public companies
Peter has represented numerous public companies across various industries in their general governance and securities matters, including Biote, Campbell Soup Company, Cotiviti, Enjoy Technology, Genworth Holdings, iLearning Engines, Infleqtion, Milestone Pharmaceuticals, Root, Solana Company, WM Holdings and Xanadu Quantum Technologies.
